Chondroitin sulfates often exist in the extracellular matrix of cartilage and connective tissue such as the artery and tendon as part of glycosaminoglycan, and show remarkable elasticity. Chondroitin sulfates are classified into certain categories based on the sulfate pattern of the repeating disaccharide moieties. In particular, chondroitin sulfate E, possessing sulfate groups at the 4 and 6 positions of the GalNAc residue, has vital biological properties. Sugahara et al. have reported that the chondroitin sulfate E polysaccharide bound specifically to midkine and inhibited neuronal cell adhesion. 1) They also found that squid cartilage chondroitin sulfate E interacted with various heparinbinding growth factors.
2) Takagaki et al. have found that chondroitin E octa or larger oligosaccharides, which had at least three continuous GlcA-GalNAc(4,6-di-S) sequences, bound to type V collagen.
3) It has recently been revealed by Miyasaka's group that the chondroitin E polysaccharide bound specifically to L-, P-selectin and chemokine. They also found that chondroitin sulfate E inhibited the binding of L-, P-selectin and chemokine to versican. 4) In order to understand these characteristics in more detail at the molecular level, structurally defined oligosaccharides of chondroitin and its sulfate, especially in the repeating region with the same and reverse sequences, are strongly required. The chondroitin sulfate repeating oligosaccharides have been synthesized mainly by two groups who adopted different types of synthetic strategy. Jacquinet's group usually constructs the sequences with -GlcA-GalNTCA or -GlcAGlcNTCA types of building blocks and has synthesized some oligosaccharides of chondroitin sulfate having a GlcA residue at the non-reducing terminal. So far as we know, they have synthesized up to the hexasaccharide of chondroitin sulfate A, 5) C 6) and D. 7) On the other hand, we have been synthesizing the reverse-type sequences by adopting the -GalN 3 -GlcA type of disaccharide moiety as a building block. The acyl-type protecting group at O-2 of the GlcA residue at the reducing end assists in the formation of the linkage for further glycan elongation. We have so far succeeded in obtaining the tetrasaccharide of chondroitin sulfate A, C and E. 8, 9) Recent reviews have arranged the synthetic progress of the chondroitin oligosaccharides. [10] [11] [12] We report here an effective synthesis of chondroitin and its sulfate E hexasaccharides (1 and 2) composed of the trimer of the -D-GalNAc(AE4,6-di-OSO 3 Na)-(1!4)--D-GlcA unit. To obtain these hexasaccharides, we adopted an acetamide strategy employing the -DGalNAc-(1!4)--D-GlcA moiety which would be applicable for the synthesis of longer chondroitin oligosaccharides.
Results and Discussion
We first tried to synthesize the target hexasaccharide sequence by the previously reported synthetic strategy 9) of employing both known azide-type donor 3 13) and acceptor 7, 9) as shown in Scheme 1. and subsequent acetylation resulted in a low yield (under 10% in 2 steps). It appears that the yield by azidereduction tended to decrease with the increasing number of azides in the molecule. In fact, the Lindlar catalystmediated reduction of azides and subsequent acetylation converted the disaccharide (monomer; 4 9) ) and tetrasaccharide (dimer; 6 9) ) to the corresponding acetamides in 90% and 60% yields, respectively. Alternatively, we have already reported that we could obtain 10 and 13 from the corresponding azides with thioacetic acid in 96% and 43% yields, respectively. 9) These results suggest that the reduction of multiple azides on oligosaccharides strongly limits the synthesis of longer chondroitin sulfates. These facts prompted us to find a new synthetic strategy to more effectively obtain longer chondroitin oligosaccharides.
We applied a synthetic strategy for glycan elongation to utilize known GlcNAc-GlcA type of disaccharide unit 10.
9) The GlcNAc-GlcA type of donor and acceptor have not previously been used for the coupling reaction in the case of chondroitin-type oligosaccharides. As depicted in Scheme 2, we converted 10 to corresponding trichloroacetimidate 11 to obtain a GlcNAc-GlcA-type donor. The methoxyphenyl group of 10 was removed with CAN in aqueous CH 3 CN, and the hemiacetal obtained was converted to imidate 11 with CCl 3 CN and DBU in CH 2 Cl 2 in 89% yield (2 steps). The usual BF 3 . OEt 2 -promoted coupling did not afford a satisfactory yield (38%) for the synthesis of 6. However, the coupling reaction of donor 11 and known acceptor 12 9) in the presence of TMSOTf and MSAW300 in CH 2 Cl 2 successfully produced 13 9) in 71% yield. TMSOTf also increased the yield of 6 (64%) in coupling conventional azide-type donor 3 and acceptor 5 (50%, employing BF 3 . OEt 2 as a promoter 8) ). It is noteworthy that a TLC analysis of the TMSOTf-mediated coupling of 11 and 12 showed a complete decomposition pattern at the beginning of the reaction, even at À20 C. However, to our surprise, the desired hexasaccharide was mainly detected after continuous stirring overnight at room temperature. We speculate that undetectable intermediates were immediately generated and might have existed for a while until a new bond was formed. Having obtained the vital dimer of GlcNAc-GlcA unit 13, in an especially high yield, the levulinoyl group of 13 was removed with H 2 NNH 2 . AcOH to yield 14 (92%). This tetrasaccharide acceptor 14 was coupled with 11 under the same reaction conditions as those already mentioned to give 9 in 66% yield.
To obtain the targeted compounds, the final conversions are those shown in Scheme 3. We first removed the levulinoyl group of 9 in the same manner as that already described to afford 15 in a quantitative yield. Subsequent removal of three benzylidene acetals of 15 with camphorsulfonic acid in CH 2 Cl 2 -MeOH needed a few days to successfully complete the reaction. Heptaol 16 generated was subjected to saponification with aqueous LiOH and NaOH in turn to afford the chondroitin hexasaccharide (trimer of the GlcNAcGlcA unit, 1) as a 4-methoxyphenyl glycoside. The yield was 76% from 15. No product due to -elimination was apparent. On the other hand, the hydroxyl group of 15 was pivaloylated with pivaloyl chloride in pyridine to give 17 in 89% yield. The benzylidene acetals were then quantitatively removed to give 18 as already described, and the six liberated hydroxyl groups were sulfated with an excess amount of SO 3 . Me 3 N in DMF at 57 C for 2 days to afford hexasulfate 19 in 91% yield. Saponification of 19 was then conducted as described to give desired chondroitin E hexasaccharide 2 in 57% yield.
In summary, we found a superior glycan elongation system with the GlcNAc-GlcA-type unit in the presence of TMSOTf in CH 2 Cl 2 . The disaccharide unit possesses acetamide to avoid struggling with the reduction of azides on the longer oligosaccharides. We have thus established an effective strategy for chondroitin oligosaccharide synthesis and have shown how to synthesize the chondroitin hexasaccharide and its sulfate E.
Experimental
Optical rotation values were measured at 22 AE 3 C with a Horiba SEPA-200 polarimeter.
1 H-NMR assignments were confirmed by two-dimensional HH COSY experiments with a Jeol ECP 500 MHz spectrometer. Signal assignments such as 1 3 stand for a proton at C-1 of sugar residue 3. MALDI-TOF and ESI mass spectra were recorded with a Daltonic autoflex (Bruker) spectrometer and Q-TOF2 (Micromass) instrument, respectively. Silica gel chromatography, analytical TLC, and preparative TLC (PTLC) were respectively conducted in a column of silica gel 60 (Merck), a column of silica gel 60N (spherical neutral; Kanto Kagaku), and on glass plates coated with silica gel F 254 (Merck). The gels for size-exclusion chromatography (Sephadex LH-20 and LH-60, and Biobeads S-X1) were purchased from Amersham Biosciences and Bio-Rad, respectively. Molecular sieves (MS) were purchased from GL Science and activated at 180 C under reduced pressure prior to use. All reactions in organic solvents were performed under a dry Ar atmosphere. The usual work-up involved the organic phase of the reaction mixture being successively washed with aqueous NaHCO 3 and brine, and dried over anhydrous MgSO 4 .
9) (6, 94.5 mg, 58.1 mol) was dissolved in a mixture of EtOH-toluene (5:1, 9 ml), and hydrazine acetate (89.7 mg, 0.97 mmol) was added while stirring for 2 h prior to removing the solvents in vacuo. The residue was subjected to purification by gel-permeation chromatography (LH- (3, 13) 104.6 mg, 108.7 mol) and 7 (107.0 mg, 70.0 mol) in toluene (7 ml) in the presence of MS 4A (0.7 g) was stirred for 30 min at room temperature and then cooled to À20 C. To this mixture, a solution of BF 3 . OEt 2 (2 l, 16 mol) in toluene (50 l) was added.
Additional promoter solution (200 l, 87 mol) was supplied until the glycosyl donor had disappeared by TLC. The reaction was quenched 10 min later with aqueous NaHCO 3 before being diluted with CHCl 3 and filtered with Celite. The organic phase was worked up in the usual manner. The crude product was eluted from a gel permeation column (S-X1, toluene) to give (10, 9) 172.7 mg, 0.184 mmol) in CH 3 CN (8 ml) and H 2 O (2 ml) was added CAN (500 mg, 0.91 mmol) while stirring for 1 h. The reaction mixture was diluted with CHCl 3 and brine. The organic phase was washed with brine and dried over anhydrous MgSO 4 . The crude product was eluted from a column of silica gel with toluene-EtOAc (3:2-2:1-1:5)-EtOAc-MeOH (50:1) to give the corresponding hemiacetal (125.7 mg) which was diluted with CH 2 Cl 2 (5 ml). To this solution were added CCl 3 CN (0.5 ml) and 1 drop of DBU while stirring at 0 C. Additional CCl 3 CN (0.2 ml) was added after 30 min at room temperature, and all the reaction mixture was eluted from a column of silica gel with toluene-EtOAc (2:1-1:50) to afford 11 (131.1 mg) in 73% yield in 2 steps. This compound was used for glycosylation without further purification. Rf 0.58 (EtOAc-MeOH 10:1 (13) . To a solution of 11 (1.18 g, 1.21 mmol) and methyl (2- (12, 858 .6 mg, 1.02 mmol) in CH 2 Cl 2 (43 ml) was added MSAW300 (5 g). The mixture was stirred for 1 h at room temperature and then cooled to À20 C. TMSOTf (213 l, 1.18 mmol) was next added while continuing stirring for 1 d and gradually increasing to room temperature. Et 3 N, aqueous NaHCO 3 , and CHCl 3 were finally added to the mixture. The insoluble materials were removed by filtering through Celite, and the organic phase was treated in the conventional manner. The crude materials obtained were passed through a gel permeation column (LH-20, CHCl 3 -MeOH 1:1) and silica gel column eluted with toluene-EtOAc (2:1-1:1-1:2) to give 13 (1.20 g) in 71% yield. The physical data were in good agreement with values previously reported. (1) . Camphorsulfonic acid (4.2 mg, 0.32 mmol) was added to a solution of 15 (17.8 mg, 7.82 mol) in CH 2 Cl 2 (0.8 ml) and MeOH (0.8 ml) while stirring. Additional camphorsulfonic acid (6.6 mg) was added after 12 h, and stirring was continued for a further 24 h. An excess amount of DIPEA was added to the reaction mixture, and the volatiles were removed under reduced pressure. The residue was subjected to gel permeation chromatography (LH-20 column, eluted by CHCl . To a solution of 15 (28.7 mg, 12.6 mol) in pyridine (1.5 ml) were added pivaloyl chloride (30 l, 80 mol) and a catalytic amount of DMAP at 80 C. After 3 h, additional pivaloyl chloride (90 l, 0.24 mmol) was added. The reaction was quenched with an excess amount of MeOH at room temperature after 2 h. The reaction mixture was evaporated, and the residue was subjected to gel permeation chromatography (LH-20 column, eluted by CHCl 3 -MeOH 1:1) to give 17 (27.0 mg) in 89% yield. This compound was used for the next reaction without further purification. Rf 0.14 (EtOAc-toluene 2:1 
